Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Comparison of Idarubicin and High-dose Daunorubicin in Combination With Cytarabine in the Induction Chemotherapy for Acute Myeloid Leukemia

NCT01145846 is registered in ClinicalTrials.gov with Cooperative Study Group A for Hematology as lead sponsor.

NCT NCT01145846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01145846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Comparison of Idarubicin and High-dose Daunorubicin in Combination With Cytarabine in the Induction Chemotherapy for Acute Myeloid Leukemia
Lead sponsor
Cooperative Study Group A for Hematology
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2010
Completion date
April 30, 2014
Enrollment
316 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia